Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.
1995 • 1,968 citations
Alpha-lipoic acid as a biological antioxidant
1995 • 1,920 citations
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
1994 • 1,311 citations
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
1997 • 1,304 citations
Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
1994 • 791 citations
The Pathogenesis of Senile Plaques
1997 • 717 citations
APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1
1997 • 640 citations
Amyloid-β peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease
1997 • 416 citations
Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain
1997 • 211 citations
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide
1997 • 171 citations
Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type
1995 • 168 citations
Free radical damage, iron, and Alzheimer's disease
1995 • 133 citations
Cytosolic and Mitochondrial Systems for NADH- and NADPH-dependent Reduction of α-Lipoic Acid
1997 • 129 citations
Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease
1996 • 119 citations
τ Protein from Alzheimer's Disease Patients Is Glycated at Its Tubulin‐Binding Domain
1995 • 107 citations
What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose
1997 • 77 citations
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation
1994 • 70 citations
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease
1998 • 57 citations
Formation of advanced glycation end (AGE) products in diabetes: prevention by pyruvate and alpha-keto glutarate.
1997 • 31 citations
Advanced glycosylation endproducts: Role in diabetic and non‐diabetic vascular disease
1994 • 28 citations
Inhibition of nitric oxide formation by aminoguanidine: An attempt to prevent insulin-dependent diabetes mellitus
1997 • 23 citations